
What We're Reading: Trump's Testing Remarks Criticized; NIH Ends Hydroxychloroquine Trial; Managing OCD Amid Pandemic
Public health experts and presidentail staffers express frustration over coronavirus disease 2019 (COVID-19) testing comments made by President Trump; the NIH has halted a clinical trial of hydroxychloroquine after data show no harm or benefit in patients with COVID-19; individuals who have obsessive-compulsive disorder may be at greater risk due to added stress from the pandemic.
Public Health Experts Rebuke Trump’s Testing Remarks
Public health experts and staffers from the Trump administration both expressed frustration over comments the President made during a campaign rally on Saturday, in which he said he asked officials to slow down testing for coronavirus disease 2019 (COVID-19). Reported by
NIH Stops Clinical Trial of Hydroxychloroquine
On Saturday, the NIH issued a
How Are Those With OCD Faring Amid the Pandemic?
A piece by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.